United Breweries Co Inc
CCU
10.95
-0.14
-1.26%
United Breweries Co Inc
US · CCU
#2782 by market cap
Listed 1970
10.95
-0.14
-1.26%
Live - 5344 symbols - heartbeat 423s ago
· 2026-10-07 19:54
After-hours
10.95
0.00%
- Market cap
- 2.02B
- P/E (TTM)i
- 19.11
- P/Bi
- 1.39
- EPSi
- 0.65
- Div yieldi
- 3.17%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on CCU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.62, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.17% YoY
Margins
- Gross margin
- 44.39%
- Operating margin
- 7.27%
- Net margin
- 4.03%
Key ratios & quality
- Enterprise valuei
- 689.39B
- Altman Z-Scorei
- 1.62
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.78T | 1.82T | 1.86T | 2.48T | 2.71T | 2.57T | 2.90T | 2.91T |
| Gross profit | 923.27B | 914.22B | 873.56B | 1.19T | 1.20T | 1.19T | 1.31T | 1.29T |
| Selling & admin expenses | 466.77B | 464.52B | 475.91B | 599.99B | 691.61B | 667.38B | 751.34B | 753.30B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 241.00B | 209.16B | 167.72B | 309.77B | 227.55B | 249.99B | 224.03B | 211.41B |
| Pretax profit | 458.21B | 185.62B | 143.60B | 301.68B | 135.75B | 103.16B | 165.53B | 110.24B |
| Tax | 136.13B | 39.98B | 35.41B | 82.63B | 263.94M | -15.27B | -11.02B | -27.05B |
| Net profit | 322.08B | 145.65B | 108.19B | 219.05B | 135.48B | 118.43B | 176.54B | 137.29B |
| Basic EPS | 1.66K | 704 | 520 | 1.08K | 640 | 572 | 871 | 634 |
| Diluted EPS | 1,661.10 | 704.42 | 520.44 | 1,078.00 | 639.60 | 571.86 | 871.14 | 634.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 817.67B | 579.91B | 658.63B | 853.41B | 819.52B | 607.80B |
| Gross profit | 382.18B | 236.83B | 279.94B | 392.64B | 387.52B | 252.83B |
| Selling & admin expenses | 201.12B | 176.18B | 169.82B | 206.17B | 209.80B | 179.19B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 87.64B | -18.73B | 36.02B | 106.07B | 90.09B | -10.50B |
| Pretax profit | 65.20B | -47.60B | 8.38B | 84.26B | 77.27B | -42.88B |
| Tax | 3.71B | -36.39B | -12.30B | 17.93B | 18.22B | -22.40B |
| Net profit | 61.49B | -11.21B | 20.69B | 66.33B | 59.05B | -20.48B |
| Basic EPS | 313 | -61 | 84 | 298 | 292 | -112 |
| Diluted EPS | 312.74 | -60.72 | 83.88 | 298.20 | 291.50 | -112.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 941.01B | 789.28B | 960.01B | 1.09T | 1.66T | 1.60T | 1.77T | 1.51T |
| Cash & ST investments | 330.02B | 202.62B | 403.72B | 279.58B | 609.04B | 621.47B | 707.95B | 520.39B |
| Inventory | 236.95B | 242.38B | 242.90B | 366.66B | 497.97B | 441.25B | 477.34B | 442.00B |
| Total assets | 2.41T | 2.35T | 2.53T | 2.85T | 3.60T | 3.42T | 3.99T | 3.65T |
| Total current liabilities | 645.72B | 483.28B | 521.52B | 781.12B | 797.15B | 687.48B | 860.01B | 795.65B |
| Short-term debt | 42.61B | 54.05B | 50.38B | 90.41B | 174.73B | 70.29B | 149.14B | 175.57B |
| Long-term debt | 210.48B | 233.56B | 412.88B | 454.23B | 1.17T | 1.22T | 1.23T | 1.03T |
| Total liabilities | 1,016,748,973,000.00 | 910,763,491,000.00 | 1,116,517,857,000.00 | 1,421,235,334,000.00 | 2,159,109,926,000.00 | 2,086,563,699,000.00 | 2,317,201,680,000.00 | 2,028,926,466,000.00 |
| Total equity | 1.39T | 1.44T | 1.41T | 1.43T | 1.44T | 1.34T | 1.67T | 1.62T |
| Retained earnings | 868.48B | 902.86B | 921.81B | 832.18B | 843.05B | 895.87B | 965.78B | 1.02T |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.72T | 1.38T | 1.45T | 1.51T | 1.51T | 1.21T |
| Cash & ST investments | 772.33B | 511.26B | 499.89B | 520.39B | 612.72B | 348.15B |
| Inventory | 463.49B | -- | 484.70B | 442.00B | 430.39B | 442.64B |
| Total assets | 3.91T | 3.51T | 3.60T | 3.65T | 3.75T | 3.46T |
| Total current liabilities | 796.89B | 645.49B | 704.17B | 795.65B | 741.93B | 655.95B |
| Short-term debt | 136.31B | 161.15B | 154.70B | 175.57B | 132.05B | 165.52B |
| Long-term debt | 1.21T | 1.10T | 1.07T | 1.03T | 1.05T | 1.04T |
| Total liabilities | 2,237,902,868,000.00 | 1,902,593,000,000.00 | 1,977,042,153,000.00 | 2,028,926,466,000.00 | 2,005,583,327,000.00 | 1,912,624,217,000.00 |
| Total equity | 1.68T | 1.61T | 1.62T | 1.62T | 1.74T | 1.55T |
| Retained earnings | 994.67B | 986.69B | 994.67B | 1.02T | 1.05T | 1.04T |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 297.87B | 101.83B | 157.88B | 121.50B | -157.67B | 164.65B | 127.43B | 82.15B |
| Dividends paid | -74.83B | -218.04B | -102.14B | -274.14B | -158.32B | -65.58B | -81.80B | -78.32B |
| Stock buybacks / issuance | -- | -- | 0 | 0 | 1.65B | 2.77B | 2.75B | 230.14M |
| Ending cash balance | 319.01B | 196.37B | 396.39B | 265.57B | 597.08B | 618.15B | 707.12B | 519.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -32.26B | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 98.67B | -32.26B | -28.50B | 81.71B | 131.84B | -48.67B |
| Dividends paid | -29.18M | -- | -1.50B | -28.65B | 0 | -41.26B |
| Stock buybacks / issuance | 230.14M | -- | 0 | 0 | 3.31B | 0 |
| Ending cash balance | 771.44B | 511.26B | 498.78B | 519.18B | 611.57B | 346.97B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 25.78 | 9.98 | 7.33 | 15.30 | 9.01 | 8.34 | 11.73 | 7.82 |
| ROA %i | 14.01 | 5.47 | 3.94 | 7.41 | 3.67 | 3.01 | 4.34 | 3.07 |
| ROIC %i | 21.99 | 8.86 | 6.71 | 11.71 | 7.49 | 5.09 | 7.44 | 5.49 |
| 5-year avg ROE %i | 14.18 | 14.07 | 13.22 | 14.06 | 13.48 | 9.99 | 10.34 | 10.44 |
| EBIT margin %i | 27.02 | 11.71 | 9.28 | 13.58 | 7.81 | 7.02 | 9.04 | 6.54 |
| FCF / sales %i | 16.70 | 5.59 | 8.50 | 4.89 | -- | 6.42 | 4.39 | 2.82 |
| Current ratioi | 1.46 | 1.63 | 1.84 | 1.40 | 2.08 | 2.33 | 2.06 | 1.90 |
| Quick ratioi | 1.04 | 1.08 | 1.33 | 0.86 | 1.39 | 1.61 | 1.45 | 1.29 |
| Debt / assetsi | 11.25 | 13.42 | 19.42 | 20.15 | 38.18 | 38.82 | 35.46 | 34.29 |
| LT debt / equityi | 17.81 | 19.71 | 33.94 | 36.96 | 91.09 | 103.33 | 82.97 | 72.99 |
| Interest coveragei | 20.45 | 7.70 | 6.00 | 9.46 | 2.79 | 2.34 | 2.70 | 2.38 |
| Revenue CAGR (3Y) %i | 5.97 | 5.35 | 3.03 | 11.69 | 14.16 | 11.36 | 5.34 | 2.38 |
| Net income CAGR (3Y) %i | 36.45 | 3.19 | -9.47 | -13.42 | -3.17 | 3.19 | -6.86 | -0.29 |
| FCF CAGR (3Y) %i | 50.27 | 18.54 | 5.00 | -25.84 | -- | 1.41 | 1.60 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.23 | 10.36 | 9.41 | 7.82 | 7.26 | 7.15 |
| ROA %i | 4.36 | 4.23 | 3.75 | 3.07 | 2.96 | 2.97 |
| ROIC %i | 7.42 | 5.38 | 6.40 | 5.49 | 5.10 | 5.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.72 | 8.11 | 7.19 | 6.54 | 6.86 | 6.90 |
| FCF / sales %i | 5.03 | 4.58 | 3.74 | 2.82 | 3.96 | 4.64 |
| Current ratioi | 2.16 | 2.14 | 2.06 | 1.90 | 2.04 | 1.84 |
| Quick ratioi | 1.53 | 0.79 | 1.32 | 1.29 | 1.40 | 1.12 |
| Debt / assetsi | 35.39 | 35.97 | 35.36 | 34.29 | 32.67 | 36.20 |
| LT debt / equityi | 81.35 | 74.65 | 75.46 | 72.99 | 68.90 | 76.33 |
| Interest coveragei | 2.63 | -- | 2.47 | 2.38 | 2.58 | 2.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Chile is the largest reported line at 65.02% of revenue, across 4 reported segments.
- International Business follows at 24.42%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Chile65.02%
International Business24.42%
Wines10.80%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.